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Abstract
Background: Dysfunctional CFTR in the airways is associated with elevated levels of NFkB mediated IL-8 signaling leading to
neutrophil chemotaxis and chronic lung inflammation in cystic fibrosis. The mechanism(s) by which CFTR mediates
inflammatory signaling is under debate.
Methodology/Principal Findings: We tested the hypothesis that wt-CFTR down-regulates NFkB mediated IL-8 secretion.
We transiently co-expressed wt-CFTR and IL-8 or NFkB promoters driving luciferase expression in HEK293 cells. Wt-CFTR
expression in HEK293 cells suppresses both basal and IL1b induced IL-8, and NFkB promoter activities as compared to the
control cells transfected with empty vector (p,0.05). We also confirmed these results using CFBE41o- cells and observed
that cells stably transduced with wt-CFTR secrete significantly lower amounts of IL-8 chemokine as compared to non-
transfected control cells. To test the hypothesis that CFTR must be localized to cell surface lipid rafts in polarized airway
epithelial cells in order to mediate the inflammatory response, we treated CFBE41o- cells that had been stably transduced
with wt-CFTR with methyl-b-cyclodextrin (CD). At baseline, CD significantly (p,0.05) induced IL-8 and NFkB reporter
activities as compared to control cells suggesting a negative regulation of NFkB mediated IL-8 signaling by CFTR in
cholesterol-rich lipid rafts. Untreated cells exposed to the CFTR channel blocker CFTR-172 inhibitor developed a similar
increase in IL-8 and NFkB reporter activities suggesting that not only must CFTR be present on the cell surface but it must
be functional. We verified these results in vivo by comparing survival, body weight and pro-inflammatory cytokine response
to P. aeruginosa LPS in CFTR knock out (CFKO) mice as compared to wild type controls. There was a significant (p,0.05)
decrease in survival and body weight, an elevation in IL-1b in whole lung extract (p,0.01), as well as a significant increase in
phosphorylated IkB, an inducer of NFkB mediated signaling in the CFKO mice.
Conclusions/Significance: Our data suggest that CFTR is a negative regulator of NFkB mediated innate immune response
and its localization to lipid rafts is involved in control of inflammation.
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Introduction
Cystic fibrosis (CF) is an autosomal recessive disorder caused by
mutations in the gene encoding the CF transmembrane conduc-
tance regulator (CFTR), a cAMP dependent and ATP-gated
chloride channel that regulates epithelial surface fluid secretion in
respiratory and gastrointestinal tracts [1]. Deletion of phenylala-
nine at position 508 (DF508) in CFTR is the most common cystic
fibrosis causing mutation, resulting in a temperature sensitive
folding defect, retention of the protein in the endoplasmic
reticulum (ER) and subsequent degradation by the proteasome
[2]. CF patients exhibit a typical phenotype that is characterized
by persistent pulmonary infections, leading to pulmonary failure
and death. Bronchoalveolar fluid (BAL) in CF patients contains
increased levels of proinflammatory cytokines and neutrophils. CF
cells have increased basal levels of pro-inflammatory C-X-C
chemokine, interleukin (IL)-8, attributed to activated NFkB [3].
IL-8, the C-X-C chemokine, is a potent chemoattractant for
neutrophils [4] that has been implicated in a number of
inflammatory diseases, such as cystic fibrosis (CF) [5], adult
respiratory distress syndrome [6], chronic obstructive pulmonary
disease (COPD), and asthma [7]. The airway epithelium is one of
the several sources of IL-8 in the airway [8]. The airway
epithelium serves as a barrier against invading microorganisms.
Airway epithelial release of IL-8 contributes to host defense by
promoting neutrophil chemotaxis and airway inflammation. The
exaggerated inflammatory responses in chronic diseases such as
CF contribute to neutrophil-driven lung destruction [9–11].
Several cytokines such as IL1-b, tumor necrosis factor (TNF)-a,
interferon (IFN)-c and bacterial products, induce NFkB mediated
IL-8 release from airway epithelial cells [12,13], thus exacerbating
the baseline inflammatory milieu in CF.
Although it has been almost two decades since the identification
of the CFTR gene, we still do not fully understand the progression
from chronic inflammation to bronchiectasis and end-stage CF
lung disease[14,15]. Excessive inflammation in the CF airway may
be largely responsible for the development of bronchiectasis, but it
has not been clear if chronic infection is always a factor[16,17].
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airways is associated with the elevated levels of NFkB mediated IL-
8 signaling leading to neutrophil chemotaxis and chronic lung
inflammation [14]. However, there is little consensus on the
mechanism(s) which link mutant CFTR to chronic lung inflam-
mation. In this study, we tested the hypothesis that functional
CFTR on cell surface and its localization to cholesterol-rich lipid
rafts is required for controlling both NFkB activity and
downstream inflammatory signaling. Our results show that the
expression of functional CFTR on cell surface negatively regulates
the NFkB mediated innate immune response.
Results
CFTR negatively regulates NFkB and IL-8 signaling
We and others have demonstrated that epithelial secretion of
interleukin (IL)-8 is elevated at baseline in bronchial epithelial cells
from human CF subjects [18–20]. This hyper-inflammatory
response was also observed in both human CF respiratory
epithelial cell lines[21] and in CF transmembrane conductance
regulator deficient homozygous mice (CFTR2/2) compared to
normal controls after Pseudomonas aeruginosa stimulation [22]. To
study the link between CFTR and NFkB activation, we over-
expressed wt-CFTR in HEK293 cells and verified transfection
efficiency by cell surface immunofluorescence microscopy. We
tested the response to IL1-b, TNFa and Pseudomonas aeruginosa LPS
by induction of NFkB- or IL-8- reporter activities (1.2–2 fold) and
selected IL1-b for further in vitro studies based on its prominent
and stable proinflammatory stimulus. In baseline conditions and
after stimulation with IL-1b, IL-8 and NFkB (Fig 1) promoter-
driven luciferase expression was suppressed greater than 2 fold by
wt-CFTR as compared to the control cells transfected with empty
vector (p,0.05). In cells co-transfected with the IL-8-DNFkB
promoter, in which we deleted the NFkB transcription site, wt-
CFTR no longer reduced the IL-8 promoter activity. We also
verified these results by quantitation of basal and IL1-b induced
IL-8 chemokine secretion in CFBE41o- and CFBE41o-wt-CFTR
cells. Stable wt-CFTR expression blunts the basal (p,0.05) and
IL1-b induced IL-8 chemokine secretion in CFBE41o- cells (Fig 2).
Our results confirm that CFTR negatively regulates NFkB
mediated IL-8 signaling.
Localization of CFTR in lipid rafts is required to regulate
NFkB and IL-8 signaling
It was recently reported that methyl-b-cyclodextrin (CD), a
membrane cholesterol scavenger reduces both the basal and
stimulated amount of CFTR in detergent resistant membranes
(DRMs)[23]. The absence of CFTR in DRMs was associated with
abnormal TNFR1 signaling as verified by no recruitment of
TNFR1 and c-Src to lipid rafts in CFTR-DTRL cells and loss of
regulation of gap junctional communication (GJIC) and IL-8
secretion[23]. These results suggest that localization of CFTR in
lipid rafts in association with c-Src and TNFR1 provides a
responsive signaling complex to regulate GJIC and cytokine
signaling. To verify these results, we used NFkB and IL-8 reporter
assays to quantify the impact of CFTR inhibition from DRMs in
CFBE41o-wt-CFTR cells. Under conditions that deplete CFTR
localization to cholesterol-rich lipid rafts, CD treatment signifi-
cantly induced (.2 fold; p,0.05) NFkB and IL8 reporter activities
in CFBE41o-wtCFTR cells as compared to control untreated cells
(Fig 3A). These data confirm that CFTR is a negative regulator of
NFkB mediated IL-8 signaling and demonstrates the importance
of lipid raft localization of CFTR (Fig S1) for its NFkB-regulatory
function. We also observed that there is no change in NFkB
reporter activity with CD treatment in HEK293 cells in absence of
CFTR indicating that CD modulates lipid-raft mediated NFkB
activity through CFTR (Fig S2). We next hypothesized that
inhibition of wt-CFTR function with CFTR-172 inhibitor in
CFBE41o-wtCFTR cells would produce a similar effect on
inflammatory signaling as CD. Treatment with CFTR-172
inhibitor induces NFkB( .2 fold) and IL-8 ($1.33 fold) reporter
activities (Fig 3B, p,0.05) supporting the hypothesis that
functional CFTR is required for regulating NFkB mediated IL-8
signaling. Our data predicts that the absence of functional CFTR
from lipid rafts or cell surface may contribute to a chronic
inflammatory state in the presence of Pseudomonas aeruginosa
infection in human CF subjects or murine model.
CFTR is required for recovery from LPS induced
inflammation
To test the hypothesis that CFTR regulates the proinflammatory
response and absence of CFTR results in chronic inflammation in
presence of P. aeruginosa, we quantified changes in LPS induced
systemic immune response in FABP-gut corrected CFTR knock out
(CFKO) and wild type (wt-) mice. Mice (n=12) were injected with
P. aeruginosa LPS or live bacteria as described in the Methods. We
compared body weight, survival and pro-inflammatory response in
sera and whole lung protein over 7 days in CFKO mice as
compared to wild type controls. Wt- and CFKO- mice both
experience a significant (p,0.05) decrease in body weight (Fig 4)
although wt- mice can recover from weight loss by day 7 but CFKO
mice do not. The box and whisker plot analysis of data was used to
determine the variation and central tendency of the replicates (body
weights) at each time point (Fig S3). Even more striking is the
observation that CFKO mice have 25% lower survival (p,0.05) as
compared to their wt- counterparts at similar LPS doses (Fig 5). The
inability of CFKO mice to recover from weight loss and decreased
survival suggest that CFTR is required for systemic immune
response to LPS. Both our in vitro (Fig 1, 2&3) and in vivo (Fig 4&5)
data clearly indicate the negative correlation between CFTR cell
surface levels and NFkB mediated inflammatory signaling.
CFTR negatively regulates IkB-NFkB mediated
inflammatory signaling in murine lung
We hypothesized that the activated phosphorylated form of IkBa
(an inducer of NFkB) would be increased in CF mice exposed to P.
aeruginosa LPS or bacteria, and that wt-mice would have lower levels
because CFTR was negatively regulating signaling via TNFa-IL-1b-
TLR. We measured phosphorylated IkBa levels in murine lungs by
immunoblotting of whole lung protein extracts from the CFKO- and
wt- mice. As canbe seen in Fig 6A&B,therewasa significantincrease
in phosphorylated IkBa from CFKO lung (p,0.01), as compared to
the wild types (n=3). At this exposure level of the blot we did not see
any signal from the wt-mice. We quantified 4.5-fold (p,0.05, n=3)
increase in IkBa-p protein levels in CFKO lungs over wt- that verifies
the significant increase in baseline IkBa-p levels in CFKO mice. The
proinflammatory stimulus (LPS or bacteria), do not aggravate this
increase. We then measured changes in downstream proinflamma-
tory signaling by quantifying IL1-b cytokine levels and observed a
steep increase by 6 hrs of LPS treatment. Both 6 and 24 hrs LPS
treatments result in significantly higher IL1-b cytokine levels in
CFKO mice as compared to the wild type (Fig 6B). We also observed
a significant induction of IL1-b by 24 hrs of P. aeruginosa LPS in
DF508- and wt- mice (,1.2–2 fold; p,0.01) although this induction
was much lower than seen in CFKO (,10 fold; p,0.01) in a parallel
experiment. Moreover, DF508-mice showed 100% survival after LPS
induced inflammation, similar to the wild types. This observation can
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DF508-CFTR is more efficient at trafficking to the cell surface when
compared to human DF508- CFTR [24]. Hence we suspect that
DF508-mice fail to mimic the severe inflammatory phenotype seen in
humans with CF in part because the trafficking of murine DF508- is
more efficient. [24].
Discussion
The cystic fibrosis transmembrane conductance regulator
(CFTR) gene was identified nearly two decades ago, however it
remains unclear whether chloride transport through CFTR is a
critical regulator of both epithelial fluid balance and inflammatory
signaling. Numerous studies have shown that inflammatory
signaling through the NFkB pathway is increased in CF lungs
and that this is linked to the production of pro-inflammatory
cytokines such as interleukin-8 (IL-8)[25–29]. However, there is
little consensus on the mechanism(s) which link CFTR or its
heritable mutant forms to chronic lung inflammation. In this
study, we tested the hypothesis that wild-type CFTR regulates
NFkB activity and IL-8 chemokine secretion. Our results show
that CFTR cell surface expression, lipid raft localization and
uninhibited channel function correlates inversely with NFkB and
IL-8 promoter activities, and downstream inflammatory signaling.
Figure 1. CFTR downregulates IL-8 and NFkB reporter activities. HEK293 cells were transiently transfected with wt-CFTR and IL-8 (A) or NFkB
(B) reporter constructs together with a renila luciferase internal control plasmid (n=3). The cells were induced with 1 ng/ml IL1-b overnight. Data are
normalized to the renila luciferase internal control and expressed as mean6SD. A. IL-8 promoter driven luciferase expression. IL1-b stimulates IL-8
promoter activity and wt-CFTR blunts both control and IL1-1b driven IL-8 (*p,0.05). B. NFkB driven luciferase expression. IL-1b stimulates NFkB
promoter activity and wt-CFTR blunts both control and IL-1-b driven NFkB (*p,0.05).
doi:10.1371/journal.pone.0004664.g001
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epithelial cells, CFTR is a negative regulator of NFkB mediated
inflammatory signaling. In a much more complex in vivo system,
murine model, we confirmed that CFTR is a negative regulator of
the NFkB mediated response and absence of CFTR results in an
inherent defect in IkB-NFkB mediated innate immune response.
To investigate the precise role of CFTR in regulation of NFkB
mediated IL-8 signaling we quantified NFkB and IL-8 reporter
activities in HEK293 and CFBE41o- cells in the presence and
absence of wt-CFTR. We observed that wt-CFTR negatively
regulates both NFkB and IL-8 promoter activities (Fig 1A&B). We
also confirmed that CFTR regulates IL-8 reporter activity via
NFkB by using DNFkB-IL-8 promoter and observed that deletion
of NFkB site in IL-8 promoter releases the inhibitory effect of
CFTR on IL-8 promoter activity. Moreover, we demonstrate that
CFTR localization to lipid rafts (Fig S1) is involved in control of
inflammation (Fig 3A). Our data supports the view that in cystic
fibrosis (CF) patients with DF508-mutation, the absence of CFTR
from lipid rafts or the cell surface results in chronic inflammation
and lung disease. This data indicates that CFTR has anti-
inflammatory properties and that the hyper-inflammation found in
CF is in part due to a disruption of the signaling link between
CFTR and NFkB. This is contrary to the concept that
inflammation in the CF lung is entirely due to the loss of chloride
and sodium transport causing impaired mucociliary clearance.
Further work is required to determine whether rescue of a partially
functional CFTR will favorably impact the balance of physiolog-
ical and inflammatory pathways. A better understanding of these
pathways could lead to new treatments for inflammation in CF,
resulting in prolonged better quality of life for these patients.
Although it is currently not clear how mutations in CFTR lead
to abnormalities of the NFkB pathway, our findings demonstrate
that lack of functional CFTR on cell surface and not just
accumulation of misfolded CFTR in the endoplasmic reticulum or
some other by-product of the CTFR mutation leads to abnormal
function of the NFkB pathway. Weber et al. recently evaluated
cells with CFTR mutations that produce proteins that are
trafficked normally to the cell membrane but lack Cl
2 channel
function. The G551D and DF508 mutations were associated with
up regulation of NFkB activation and increased production of IL-
8[30]. They concluded that cell lines with defective CFTR Cl
2
channel activity, regardless of the type of CFTR defect, have a
proinflammatory phenotype. Elucidating the mechanisms by
which abnormal Cl
2 channel function deregulates NFkB
activation in CF is an important area for further investigation.
Recently, Marc Chanson, Bruce Stanton and colleagues demon-
strated that deletion of the PDZ binding domain of CFTR
(CFTR-DTRL) not only compromises the ability of CFTR to
localize to gap junction TNFa protein-complex but also results in
activation of downstream NFkB signaling. The absence of CFTR
in detergent resistant membranes (DRMs) was associated with
abnormal TNFR1 signaling as verified by lack of recruitment of
TNFR1 and c-Src to lipid rafts in CFTR-DTRL cells and loss of
regulation of gap junctional communication (GJIC) and IL-8
secretion[23]. These results suggest that localization of CFTR in
detergent resistant and cholesterol rich lipid rafts in association
with c-Src and TNFR1 provides a responsive signaling complex to
regulate GJIC and NFkB mediated cytokine signaling. This
supports the idea that when DF508 CFTR is inefficient in
trafficking, there is exaggerated NFkB mediated signaling due to
lack of gap junctional communication (GJIC) of CFTR with
TNFa or IL1-b receptors. We and others have observed that
transient or stable over expression of DF508-CFTR in HEK-293
or CFBE cells results in decreased NFkB transcriptional activity
(Fig S4), but expression of another type of CFTR mutation does
not[31–33]. In spite of the fact that over expression of misfolded
DF508 CFTR results in endoplasmic reticulum overload and UPR
activation[31–33], we anticipate that cell surface expression of
over expressed mutant CFTR will inhibit the NFkB activity (as
seen in Fig S4) and this warrants further investigation.
NFkB mediated IL-8 chemokine secretion and neutrophil
influx, are prominent and early features of CF. It is proposed
that airway inflammation may occur before or in the absence of
bacterial infection. Several recent reports have demonstrated that
lung epithelial cells expressing mutant CFTR have increased
production of proinflammatory cytokines and exaggerated NFkB-
activation[25–29]. GB Pier and colleagues have demonstrated a
role for CFTR in airway epithelial cell endocytosis of Pseudomonas
Figure 2. CFTR downregulates IL-8 chemokine secretion. CFBE41o- control and cells stably transduced with wt-CFTR were induced with 1 ng/
ml IL1-b and IL-8 chemokine secretion in media was calculated after overnight treatment. Data are shown as mean6SD of three experiments. IL1-b
stimulates IL-8 chemokine secretion while wt-CFTR blunts both control and IL1-1b driven IL-8 chemokine secretion (*p,0.05).
doi:10.1371/journal.pone.0004664.g002
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molecule that extracts P. aeruginosa LPS from outer membrane into
epithelial cells and activates NFkB signaling [34,35]. They
hypothesize that the lack of this initial IL1-b-NFkB proinflamma-
tory signaling[36] in DF508- CF patients results in chronic airway
inflammation. In contrast, other groups believe that CFTR
Figure 3. Inhibition of CFTR regulated NFkB signaling under conditions that disrupt lipid rafts. CFBE41o- cells stably transduced with wt-
CFTR were transiently transfected with IL-8 or NFkB reporter constructs and a renila luciferase internal control plasmid (n=3). The cells were induced
with 1 ng/ml IL1-b and/or treated with 5 mM methyl-b-cyclodextrin (CD) for 6 hrs (A), and/or 10 mM CFTR-172 inhibitor overnight (B). The data are
shown as mean6SD of IL-8 or NFkB promoter activities normalized to renila luciferase internal control. A. IL-1b induced IL-8 and NFkB promoter
driven luciferase expression, and wt-CFTR dampened baseline and cytokine induced reporter activity (Figs 1&2). Pre-treatment with CD under
conditions known to disrupt lipid rafts eliminated the effect of wt-CFTR, *p,0.05. B. Cells were transfected as in A but instead of treatment with CD,
the CFTR-172 inhibitor was included to block CFTR-mediated chloride secretion at the plasma membrane. Pre-treatment with CFTR 172 inhibitor
induced IL-8 and NFkB promoter activities and eliminated the inhibitory effect of wt-CFTR, *p,0.05.
doi:10.1371/journal.pone.0004664.g003
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to chronic lung disease. Our data for the first time demonstrate
that CFKO mice have inherently higher levels of phosphorylated
IkB (Fig 6A) supporting the notion that lack of CFTR results in
hyper-inflammatory signaling by compromising the regulatory
mechanisms of innate immunity. In addition, we observed that cell
surface localization of CFTR is required for regulation of gap
junction communication (GJIC) and response to pathogen
associated molecular patterns (PAMPs) by primary signaling
receptors (TNFa, IL1-b or TLRs) of innate defense (Fig 3A&6
and Fig S1). This may explain why mutations or single nucleotide
polymorphisms (SNPs) of these receptors have the modifier
function in CF or CF like diseases[37–39]. Our in vitro and in
vivo data clearly support the hypothesis that CFTR serves as a
negative regulator of innate immunity and both CFTR channel
function and its localization to lipid rafts are critical for controlling
NFkB mediated inflammatory signaling (Fig 7).
Recent studies have shown that localization of CFTR to DRMs
increases in presence of P. aeruginosa or proinflammatory
stimulus[23,40], we anticipate that this may be a homeostatic
mechanism to control inflammation. We also observed that not
only CFTR channel expression and its localization to DRMs but
also its channel function is required to control inflammation.
There can be two possible scenarios where CFTR channel
function can regulate proinflammatory response: 1.) cell surface or
2.) DRMs. The mechanism of first scenario is apparent but it is not
clear if functional CFTR is required in DRMs, we predict that
non-functional channels may be incapable of localization to
DRMs in presence of proinflammatory stimulus resulting in
uncontrolled inflammatory response. We are further investigating
the role of CFTR channel function in its DRM localization.
Together, these studies suggest a mechanism that links CFTR
localization in lipid rafts, and channel function to intracellular
NFkB signaling and inflammatory response. The clinical implica-
tion of these findings is that treatment of CF patients with small
molecule or therapeutic compounds that rescues optimal amount
of mutant CFTR to the cholestrol-rich cell surface lipid rafts can
inhibit the NFkB mediated chronic inflammation and rescue the
pathology induced by defective CFTR, potentially attenuating the
progression of CF or related obstructive lung diseases like COPD
and emphysema.
Figure 4. The CFTR knock out mice show significant decline in body weight after LPS treatment. The FABP-CFTR gut corrected CFTR
knock-outs (CFKO) and wt- mice (n=12) were injected i.p. with 15 mg/kg body weight of P. aeruginosa LPS, and body weights were recorded daily for
6 days. The CFKO mice show significant decline in body weight as compared to wild type mice (p,0.001; day 3–6). Wild type mice (blue) recover
from weight loss by day 6 while CFKO mice (red) don’t show significant recovery. The 25% of CFKO mice died during the course of experiment due to
LPS induced chronic inflammation (green). The data suggest that CFTR is critical for LPS induced immune response and recovery from LPS induced
inflammation. The data are shown as body weight in grams of each mouse in wt- and CFKO- group from day 0 to 6. The non-linear logarithmic
regression was used to calculate the trend lines indicating the changes in body weight in wild type (blue) and CFKO (red) mice after LPS exposure.
doi:10.1371/journal.pone.0004664.g004
Figure 5. The CFTR knock out mice show significant decline in
recovery from inflammation after LPS treatment. The FABP-CFTR
gut corrected CFTR knock-outs (CFKO) and wt- mice (n=12) were
injected i.p. with 15 mg/kg body weight of P. aeruginosa LPS, and
survival was recorded daily for 7 days. The data are shown as
percentage of mice that survived at each time point. The CFKO mice
(red) show a 25% decline in survival as compared to wild type mice
(blue) by day 4 (*p,0.05). Wild type mice show 100% survival and
recovery from inflammation at the given LPS dose while 25% of CFKO
mice fail to recover and don’t survive.
doi:10.1371/journal.pone.0004664.g005
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Cell Culture and Reagents
The HEK293, CFBE41o- (cystic fibrosis bronchial epithelial
cell lines, originally immortalized and characterized by Dr. Dieter
Gruenert[41,42]), CFBE41o-wtCFTR or CFBE41o-DF08-CFTR
(stably transduced with wt-CFTR or DF08-CFTR by Dr. JP
Clancy[43]) cell lines were maintained in DMEM/F12 and MEM
Earl’s salt L-Glutamine (200 mM L-Glutamine) medium contain-
ing 100 units/ml penicillin, 100 mg/ml streptomycin, 0.25 mg/ml
amphotericin B and 10% fetal bovine serum. The CFBE41o-
wtCFTR or CFBE41o-DF08-CFTR cells were always cultured in
presence of 500 mg/ml Hygromycin B. DMEM/F12, MEM and
other components were purchased from Gibco or Invitrogen,
Carlsbad, CA. TNF-a, IL-1b (R&D Systems Inc., Minneapolis,
MN), CFTR-172 inhibitor (Calbiochem, Gibbstown, NJ), methyl-
b-cyclodextrin and Pseudomonas aeruginosa LPS (Sigma, St. Louis,
MO) were added to cells or injected in mice as indicated.
Pseudomonas aeruginosa PAO1 strain was obtained from ATCC for
animal experiments. Sulfo-NHS-SS-Biotin was purchased from
Pierce, Rockford, IL while other common laboratory chemicals
were from Sigma.
Immunoblotting
Lung tissues were lysed by sonication (three 5 sec pulses) on ice
in cold room using the T-PER (Pierce Biotech. Inc., Rockford, IL)
protein lysis buffer containing protease-inhibitor cocktail (Pierce).
The protein extracts were suspended in Laemmli’s sample buffer
(Invitrogen) containing b-mercaptoethanol (Invitrogen), resolved
by 4–10% SDS-PAGE and transferred to a 0.45 mm pore size
nitrocellulose membrane (Invitrogen). The b-actin (Sigma) and
Figure 6. The CFTR knock out mice have elevated IkB-NFkB mediated inflammatory signaling. The FABP-CFTR gut corrected CFTR knock-
outs (CFKO) and wt- mice (n=3) were injected i.p. with 15 mg/kg body weight of P. aeruginosa LPS or live bacteria (100 ml, 2610
8), and IkB-p levels
(24 hrs) were quantified by immunoblotting while serum IL1-b levels (6 or 24 hrs) were determined by ELISA. A. The representative immunoblot
indicates the IkB-p protein levels in each group. The lung protein extracts of CFKO mice show inherent increase in IkB-p levels indicative of elevated
NFkB signaling and activation. The densitometry analysis of IkB-p protein levels in CFKO lungs as compared to wild type mice show a 4.5 fold
increase (n=3, p,0.05) at baseline. B. The serum concentration of IL1-b (pg/ml) shown as mean6SD. The CFKO mice (red) have significantly higher
pro-inflammatory cytokine, IL1-b, levels (***p,0.001 at 6 hrs while *p,0.05 at 24 hrs) on LPS induction as compared to wild type mice (green;
**p,0.01).
doi:10.1371/journal.pone.0004664.g006
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rabbit-HRP secondary antibody (Amersham, Piscataway, NJ) were
used for immunoblotting.
Animal Experiments
All animal experiments were carried out in accordance with the
Johns Hopkins University (JHU) Animal Care and Use Committee
(ACUC) approved protocol. To measure inflammatory signaling in
vivo, the age and sex matched C57BL6, FABP-CFTR gut
corrected CFTR knock-outs, DF508-homozygous and wt- mice
(n=12) were injected i.p. with 15 mg/kg body weight of P.
aeruginosa LPS, and survival and body weights were recorded daily
for 6–7 days. Serum and total lung protein extracts were isolated
at 6 and 24 hrs time points in a parallel experiment. Serum IL1-b
cytokine levels were quantified by sandwich ELISA (described
below) to identify the changes in pro-inflammatory signaling. The
total lung protein extracts from both P. aeruginosa LPS and live
bacteria (2610
8) injected (i.p.) mice were used for quantification of
IkB-p and b-actin protein levels by Western blotting.
IL-1b and IL-8 Immunoassay
At the indicated time points, serum was collected and IL-1b
levels were measured using solid-phase ELISA (R&D Bisoystems,
Minneapolis, MN). Standards, and high and low cytokine controls
were included. The plates were read at 450 nm on 96-well
microplate reader (Molecular Devices, Sunnyvale, CA) using
SOFT-MAX-Pro software (Molecular Devices). The mean blank
reading was subtracted from each sample and control reading.
Figure 7. Hypothetical model of CFTR mediated NFkB signaling and innate immune response. The lack of functional CFTR on the cell
surface or inhibition of lipid raft localization by methyl-b-cyclodextrin (CD) de-regulates pro-inflammatory signaling via TNFa-IL1b-TLR pathways
resulting in an overactive innate immune response, chronic NFkB mediated inflammation, and lung destruction. Our data suggest that localization of
functional CFTR at the cell surface in cholesterol rich lipid rafts serves as a negative regulator of NFkB signaling. We propose that restoration of an
optimal amount of functional CFTR on the cell surface can control chronic inflammatory pathophysiology of CF lung disease by not only restoring the
chloride efflux function but by also regulating the chronic NFkB mediated inflammatory signaling.
doi:10.1371/journal.pone.0004664.g007
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by measuring the absorbance which is proportional to IL-1b
concentration. A standard curve was plotted and an IL-1b
concentration in each sample was determined by interpolation
from standard curve. The data represents the mean of three
independent experiments6SD. The IL-8 chemokine secretion in
media was similarly quantified using an EASIA system (Invitrogen)
as described before[18].
Transfection, NFkB- and IL-8- Reporter Assays
CFBE41o- or HEK293 cells were transfected with NFkB- or IL-
8- (with or without the NFkB site) firefly luciferase promoter (pGL-
2) and renila luciferase (pRLTK) control, or CFTR (wt- or DF508-
GFP) constructs. Renila luciferase internal control was used for
normalization of DNA and transfection efficiency of reporter
constructs in all experiments. Transfection efficiency of CFTR
constructs and surface localization of wt-CFTR was verified by
immunofluorescence microscopy. Cells were induced with 1 ng/ml
of IL1-b, TNF-a or Pseudomonas aeruginosa LPS and luciferase
activities were measured after overnight treatment. The 10 mM
CFTR-172 inhibitor overnight or 5 mM methyl-b-cyclodextrin
(CD) 6 hrs, treatment was used to inhibit the wt-CFTR function or
itslocalization tolipid rafts,respectively. Dual-LuciferaseH Reporter
(DLRTM) Assay System (Promega) was used to measure NFkBo r
IL-8 reporter (firefly luciferase) and renila luciferace activities from
HEK293 or CFBE41o- cell extracts. Data was normalized with
internal renila luciferase control for each sample and the changes in
reporter activities with CFTR over expression were calculated.
Statistical Analysis
Representative data is shown as the mean6SD of at least three
experiments. The one-way ANOVA with a Dunnett planned
comparison was run for each sample versus control. The Box and
Whisker plot analysis was used to determine the variation in body
weights overtime and central inclination of data among the two
genotypes.A*p,0.05wasconsideredtohavestatisticalsignificance.
Supporting Information
Figure S1 In the absence of CFTR, disruption of lipid rafts does
not modulate NFkB signaling. HEK293 cells were transiently
transfected with NFkB reporter construct and a renila luciferase
internal control plasmid (n=3). The cells were induced with 1 ng/ml
IL1-b and/or treated with 5 mM methyl-b-cyclodextrin (CD) for
6 hrs. The data are shown as mean6SD of NFkB promoter activity
normalized to renila luciferase internal control. IL-1b induced NFkB
promoter driven luciferase expression, and CD treatment under
conditions known to disrupt lipid rafts has no significant effect on
NFkB promoter activity in the absence of CFTR.
Found at: doi:10.1371/journal.pone.0004664.s001 (0.69 MB EPS)
Figure S2 Box and whisker plot analysis of the CFTR knock out
mice show significant decline in body weight after LPS treatment.
The Box and whisker plot analysis was used to determine the
variation and central tendency of data at each time point. The box
represents the distance between the 1st and 3rd quartiles (Q). The
whiskers show the highest and lowest data points or 1.5 times the
box (Q3-Q1). Outlier points (X) are those that are greater than 1.5
times (Q3 -Q1). The yellow box represents the difference between
the Q3 and the median while green box indicates the difference
between the Q1 and the median. The data shows the statistical
significance of the decline in body weights of FABP-CFTR gut
corrected CFTR knock-outs (CFKO) mice as compared to the
wild type mice (n=12) from day 0 to 6. (A) Wild type mice recover
from weight loss by day 6 while (B) CFKO mice don’t show
significant recovery.
Found at: doi:10.1371/journal.pone.0004664.s002 (1.19 MB EPS)
Figure S3 Disruption of detergent resistant membranes (DRMs)
by methyl-b-cyclodextrin (CD) inhibits raft CFTR. CFBE41o- cells
stably transduced with wt-CFTR were treated with 5 mM methyl-
b-cyclodextrin (CD) for 6 hrs. The plasma membrane proteins
biotinylated with 1 mg/ml sulfo-NHS-SS-biotin for 60 min at 37uC
were isolated by Streptavidin-Sepharose pull down. The sucrose
density gradient ofthese biotin labeled membraneproteinswasused
to isolate lipid raft and soluble fractions followed by CFTR
immunoblotting. CD treatment significantly reduces the amount of
raft CFTR but has no effect on soluble CFTR. The densitometric
analysis (lower panel) of the raft CFTR bands illustrates the
inhibitory effect of CD on CFTR localization to lipid raft. The
graph shows mean+SD of duplicate experiments (*p,0.05).
Found at: doi:10.1371/journal.pone.0004664.s003 (1.26 MB EPS)
Figure S4 DF508-CFTR downregulates NFkB mediated IL-8
reporter activity. CFBE41o- controls and cells stably transduced
with DF508-CFTR were transiently transfected with IL-8 or IL8-
DNFkB reporter constructs and a renila luciferase internal control
plasmid (n=3). The cells were induced with 1 ng/ml IL1-b
overnight. Data are normalized to the internal control and
expressed as mean+SD (*p,0.05). IL-1b induced IL-8 promoter
expression and DF508-CFTR dampened baseline and cytokine
induced reporter activity. The deletion of NFkB transcription site
from IL-8 promoter (IL8-DNFkB) abolished both IL1-b meditated
IL-8 induction and inhibitory effect of DF508-CFTR.
Found at: doi:10.1371/journal.pone.0004664.s004 (0.75 MB EPS)
Acknowledgments
We thank Drs. HR Wong and D Teti for providing IL-8 promoter
constructs.
Author Contributions
Conceived and designed the experiments: NV. Performed the experiments:
NV SM. Analyzed the data: NV SM PLZ. Contributed reagents/
materials/analysis tools: NV PLZ. Wrote the paper: NV. Helped with
the editing of the paper: PLZ.
References
1. Rowe SM, Miller S, Sorscher EJ (2005) Cystic fibrosis. N Engl J Med 352:
1992–2001.
2. Thibodeau PH, Brautigam CA, Machius M, Thomas PJ (2005) Side chain and
backbone contributions of Phe508 to CFTR folding. Nat Struct Mol Biol 12:
10–16.
3. Zaman MM, Gelrud A, Junaidi O, Regan MM, Warny M, et al. (2004)
Interleukin 8 secretion from monocytes of subjects heterozygous for the
deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation
is altered. Clin Diagn Lab Immunol 11: 819–824.
4. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, et al. (1987)
Purification of a human monocyte-derived neutrophil chemotactic factor that
has peptide sequence similarity to other host defense cytokines. Proc Natl Acad
Sci U S A 84: 9233–9237.
5. Nakamura H, Yoshimura K, McElvaney NG, Crystal RG (1992) Neutrophil
elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis
induces interleukin-8 gene expression in a human bronchial epithelial cell line.
J Clin Invest 89: 1478–1484.
6. Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, et al. (1993)
Interleukin-8 and development of adult respiratory distress syndrome in at-risk
patient groups. Lancet 341: 643–647.
7. Marini M, Vittori E, Hollemborg J, Mattoli S (1992) Expression of the potent
inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and
CFTR Negatively Regulates NFkB
PLoS ONE | www.plosone.org 9 February 2009 | Volume 4 | Issue 2 | e4664interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with
asthma. J Allergy Clin Immunol 89: 1001–1009.
8. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP 3rd, et al. (1990)
Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for
cytokine networks in the lung. J Clin Invest 86: 1945–1953.
9. Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, et al. (1995)
Lower respiratory infection and inflammation in infants with newly diagnosed
cystic fibrosis. Bmj 310: 1571–1572.
10. Birrer P, McElvaney NG, Rudeberg A, Sommer CW, Liechti-Gallati S, et al.
(1994) Protease-antiprotease imbalance in the lungs of children with cystic
fibrosis. Am J Respir Crit Care Med 150: 207–213.
11. Konstan MW, Hilliard KA, Norvell TM, Berger M (1994) Bronchoalveolar
lavage findings in cystic fibrosis patients with stable, clinically mild lung disease
suggest ongoing infection and inflammation. Am J Respir Crit Care Med 150:
448–454.
12. DiMango E, Zar HJ, Bryan R, Prince A (1995) Diverse Pseudomonas aeruginosa
gene products stimulate respiratory epithelial cells to produce interleukin-8.
J Clin Invest 96: 2204–2210.
13. Massion PP, Inoue H, Richman-Eisenstat J, Grunberger D, Jorens PG, et al.
(1994) Novel Pseudomonas product stimulates interleukin-8 production in
airway epithelial cells in vitro. J Clin Invest 93: 26–32.
14. Rubin BK (2007) CFTR is a modulator of airway inflammation. Am J Physiol
Lung Cell Mol Physiol 292: L381–382.
15. Rubin BK (2003) A scientific koan: what is the cause of cystic fibrosis? Chest
123: 1792–1793.
16. Machen TE (2006) Innate immune response in CF airway epithelia:
hyperinflammatory? Am J Physiol Cell Physiol 291: C218–230.
17. Tseng J, Do J, Widdicombe JH, Machen TE (2006) Innate immune responses of
human tracheal epithelium to Pseudomonas aeruginosa flagellin, TNF-alpha,
and IL-1beta. Am J Physiol Cell Physiol 290: C678–690.
18. Vij N, Amoako MO, Mazur S, Zeitlin PL (2008) CHOP transcription factor
mediates IL-8 signaling in cystic fibrosis bronchial epithelial cells. Am J Respir
Cell Mol Biol 38: 176–184.
19. Vij N, Fang S, Zeitlin PL (2006) Selective Inhibition of Endoplasmic Reticulum-
associated Degradation Rescues {Delta}F508-Cystic Fibrosis Transmembrane
Regulator and Suppresses Interleukin-8 Levels: THERAPEUTIC IMPLICA-
TIONS. J Biol Chem 281: 17369–17378.
20. Perez A, Issler AC, Cotton CU, Kelley TJ, Verkman AS, et al. (2007) CFTR
inhibition mimics the cystic fibrosis inflammatory profile. Am J Physiol Lung
Cell Mol Physiol 292: L383–395.
21. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A (1998) Activation of NF-
kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis
respiratory epithelial cells. J Clin Invest 101: 2598–2605.
22. Heeckeren A, Walenga R, Konstan MW, Bonfield T, Davis PB, et al. (1997)
Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary
infection with Pseudomonas aeruginosa. J Clin Invest 100: 2810–2815.
23. Dudez T, Borot F, Huang S, Kwak BR, Bacchetta M, et al. (2008) CFTR in a
lipid raft-TNFR1 complex modulates gap junctional intercellular communica-
tion and IL-8 secretion. Biochim Biophys Acta 1783: 779–788.
24. Ostedgaard LS, Rogers CS, Dong Q, Randak CO, Vermeer DW, et al. (2007)
Processing and function of CFTR-DeltaF508 are species-dependent. Proc Natl
Acad Sci U S A 104: 15370–15375.
25. Blackwell TS, Stecenko AA, Christman JW (2001) Dysregulated NF-kappaB
activation in cystic fibrosis: evidence for a primary inflammatory disorder.
Am J Physiol Lung Cell Mol Physiol 281: L69–70.
26. Stecenko AA, King G, Torii K, Breyer RM, Dworski R, et al. (2001)
Dysregulated cytokine production in human cystic fibrosis bronchial epithelial
cells. Inflammation 25: 145–155.
27. Venkatakrishnan A, Stecenko AA, King G, Blackwell TR, Brigham KL, et al.
(2000) Exaggerated activation of nuclear factor-kappaB and altered IkappaB-
beta processing in cystic fibrosis bronchial epithelial cells. Am J Respir Cell Mol
Biol 23: 396–403.
28. Srivastava M, Eidelman O, Zhang J, Paweletz C, Caohuy H, et al. (2004)
Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-
8 from cystic fibrosis lung epithelial cells. Proc Natl Acad Sci U S A 101:
7693–7698.
29. Joseph T, Look D, Ferkol T (2005) NF-kappaB activation and sustained IL-8
gene expression in primary cultures of cystic fibrosis airway epithelial cells
stimulated with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol
288: L471–479.
30. Weber AJ, Soong G, Bryan R, Saba S, Prince A (2001) Activation of NF-kappaB
in airway epithelial cells is dependent on CFTR trafficking and Cl2 channel
function. Am J Physiol Lung Cell Mol Physiol 281: L71–78.
31. Bartoszewski R, Rab A, Jurkuvenaite A, Mazur M, Wakefield J, et al. (2008)
Activation of the unfolded protein response by deltaF508 CFTR. Am J Respir
Cell Mol Biol 39: 448–457.
32. Bartoszewski R, Rab A, Twitty G, Stevenson L, Fortenberry J, et al. (2008) The
mechanism of cystic fibrosis transmembrane conductance regulator transcrip-
tional repression during the unfolded protein response. J Biol Chem 283:
12154–12165.
33. Rab A, Bartoszewski R, Jurkuvenaite A, Wakefield J, Collawn JF, et al. (2007)
Endoplasmic reticulum stress and the unfolded protein response regulate
genomic cystic fibrosis transmembrane conductance regulator expression.
Am J Physiol Cell Physiol 292: C756–766.
34. Schroeder TH, Lee MM, Yacono PW, Cannon CL, Gerceker AA, et al. (2002)
CFTR is a pattern recognition molecule that extracts Pseudomonas aeruginosa
LPS from the outer membrane into epithelial cells and activates NF-kappa B
translocation. Proc Natl Acad Sci U S A 99: 6907–6912.
35. Schroeder TH, Reiniger N, Meluleni G, Grout M, Coleman FT, et al. (2001)
Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas
aeruginosa from the respiratory tract. J Immunol 166: 7410–7418.
36. Reiniger N, Lee MM, Coleman FT, Ray C, Golan DE, et al. (2007) Resistance
to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis
transmembrane conductance regulator-modulated interleukin-1 (IL-1) release
and signaling through the IL-1 receptor. Infect Immun 75: 1598–1608.
37. Collaco JM, Cutting GR (2008) Update on gene modifiers in cystic fibrosis. Curr
Opin Pulm Med 14: 559–566.
38. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, et al. (2005)
Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353:
1443–1453.
39. Knowles MR (2006) Gene modifiers of lung disease. Curr Opin Pulm Med 12:
416–421.
40. Kowalski MP, Pier GB (2004) Localization of cystic fibrosis transmembrane
conductance regulator to lipid rafts of epithelial cells is required for
Pseudomonas aeruginosa-induced cellular activation. J Immunol 172: 418–425.
41. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, et al. (1994) CFTR
expression and chloride secretion in polarized immortal human bronchial
epithelial cells. Am J Respir Cell Mol Biol 10: 38–47.
42. Bruscia E, Sangiuolo F, Sinibaldi P, Goncz KK, Novelli G, et al. (2002) Isolation
of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated
targeting. Gene Ther 9: 683–685.
43. Hentchel-Franks K, Lozano D, Eubanks-Tarn V, Cobb B, Fan L, et al. (2004)
Activation of airway cl- secretion in human subjects by adenosine. Am J Respir
Cell Mol Biol 31: 140–146.
CFTR Negatively Regulates NFkB
PLoS ONE | www.plosone.org 10 February 2009 | Volume 4 | Issue 2 | e4664